Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
DCCT.
Pregnancy outcome in the diabetes control and complications Trial.
Am J Obstet Gynecol, 174 (1996), pp. 1343-1353
[2.]
E.A. Reece, C. Homko.
Why do diabetic women deliver malformed infants?.
Clin Obstet Gynecol, 43 (2000), pp. 32-45
[3.]
M.J. Platt, M. Stanisstreet, I.F. Casson, C.V. Howard, S. Walkinshaw, S. Pennycook, et al.
St Vincent’s Declaration 10 years on: outcomes of diabetic pregnancies.
Diabet Med, 19 (2002), pp. 216-220
[5.]
American Diabetes Association.
Preconception care of women with diabetes in pregnancy.
Diabetes Care, 27 (2004), pp. S76-S78
[6.]
American Diabetes Association. Medical management of pregnancy complicated by diabetes. Third Edition, 2000. American Diabetes Association. 1701 North Beauregard Street, Alexandria, Virginia 22311.
[7.]
T.D. Diamond, N. Kormas.
Possible adverse fetal effect of insulin lispro.
New Engl J Med, 337 (1997), pp. 1009-1040
[8.]
A. Lapolla, M.G. Dalfrà, D. Fedele.
Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?.
Diabets Metab Res Rev, 21 (2005), pp. 241-252
[9.]
J. Wyatt, J. Frias, H.E. Hoyme, L. Jovanovic, F. Kaajas, et al.
Congenital anomaly rate in offspring of women with diabetes treated with insulin lispro during pregnancy.
Diabet Med, 22 (2005), pp. 803-807
[10.]
M. Hod, S. Amiel, P. Damm, F. Dunne, S. Heller, B. Lertoft, et al.
Insulin aspart in pregnancy: protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes.
Diabet Metab, 29 (2003),
[11.]
G. DiCianni, L. Volpe, C. Lencioni, K. Chatzianagnostou, I. Cuccuru, A. Ghio, et al.
Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women.
Diabetes Care, 28 (2005), pp. 982-983
[12.]
J.L. Kitzmiller, E. Main, B. Ward, T. Theiss, D.L. Peterson.
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
Diabetes Care, 22 (1999), pp. 874-875
[13.]
L. Jovanovic.
Retinopathy risk: what is responsible? Hormones, hyperglycaemia or humalog? Response to Kitzmiller et al.
Diabetes Care, 22 (1999), pp. 846-848
[14.]
F. Mecacci, L. Carignani, R. Cioni, E. Batoli, E. Parretti, P. LaTorre, et al.
Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non diabetic pregnant women.
Eur J Obstet Gynecol Reprod Biol, 111 (2003), pp. 183-186
Copyright © 2005. Sociedad Española de Endocrinología y Nutrición
